GSP shows promise as a functional supplement for T2D in rodent studies, but its therapeutic potential in humans requires rigorous clinical and translational research to validate efficacy and safety, indicating it could be a potential functional ingredient with therapeutic potential for T2D. The gene discussed is GNAS; the disease is type 2 diabetes mellitus.